Item 2. Management’s Discussion and Analysis
ITEM 2. MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion
and analysis should be read in conjunction with our unaudited condensed consolidated financial statements, and the notes thereto, and
other financial information appearing elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements
and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022. The following discussion
and analysis compares our consolidated results of operations for the three and nine months ended June 30, 2023 (the “2023 Quarter”
and “2023 Period”, respectively) with those for the three and nine months ended June 30, 2022 (the “2022 Quarter”
and “2022 Period”, respectively). All dollar amounts and percentages presented herein have been rounded to approximate
values.
Cautionary Note Regarding Forward-Looking Statements
This report contains
“forward-looking statements”, as such term is used within the meaning of the Private Securities Litigation Reform Act of
1995. These statements include, among other things, statements regarding our liquidity, plans on repaying outstanding debt
obligations, expectations regarding the effect of the pandemic and inflation on our business, as well as other statements regarding
our future operations, financial condition and prospects, and business strategies. Forward-looking statements generally can be
identified by words such as "anticipates," "believes," "estimates," "expects,"
"intends," "plans," "predicts," "projects," "will be," "will continue,"
"will likely result," and similar expressions. These forward-looking statements are based on current expectations and
assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially and adversely
from those reflected in the forward-looking statements. These risks include the inability to expand our customer base, loss of
additional customers, pricing pressures, lack of success of our sales people, continued supply chain issues, inability of our design
division’s customers to pay for our services, unanticipated issues with our affiliated sourcing agent, and issues at Chinese
factories that source our product. No assurance can be given that the actual results will be consistent with the forward-looking
statements. Investors should read carefully the factors described in the “Risk Factors” section of the Company’s
filings with the SEC, including the Company’s Form 10-K for the year ended September 30, 2022 for information regarding risk
factors that could affect the Company’s results. We undertake no obligation to revise or publicly release the results of any
revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned
not to place undue reliance on such forward-looking statements.
Business Overview
Forward Industries, Inc.
is a global design, sourcing and distribution company serving top tier medical and technology customers worldwide.
In July 2023, the Company
decided to cease its retail operations (“Retail Exit”). The Retail Exit will have no effect on the operations of our other
segments. The Company is currently working on a plan that will ensure the Retail Exit is made in an orderly manner. At the time of this filing, the Company does not know the extent, or a range, of the costs that it will incur
as a result of the exit.
Our design segment provides
hardware and software product design and engineering services to customers predominantly located in the U.S. Our OEM distribution segment
sources and sells carrying cases and other accessories for medical monitoring and diagnostic kits as well as a variety of other portable
electronic and non-electronic devices to OEMs, or their contract manufacturers worldwide, that either package our products as accessories
“in box” together with their branded product offerings or sell them through their retail distribution channels. Our retail
distribution segment sources and sells smart-enabled furniture, hot tubs and saunas, and various other products through online retailer
websites to customers predominately located in the U.S. and Canada.
The effects of the COVID-19
pandemic continue to impact our business with high capitalized inventory costs for inbound ocean freight, particularly from the Asia-Pacific
region, and expenses associated with outbound ground transportation. We expect to see the benefits of declining ocean freight costs in
future periods. Inflation, in part associated with the pandemic, continues to increase the cost of acquiring and retaining our employees
and acquiring inventory. The instability of transportation costs and future inflation are still largely unknown but are expected to continue
throughout fiscal 2023.
20
The effects of COVID-19 may
further impact our business in ways we cannot predict, and such impacts could be significant. The current economic conditions may continue
to negatively impact our results of operations, cash flows and financial position in future periods as well as that of our customers,
including their ability to pay for our services and to choose to allocate their budgets to new or existing projects which may or may not
require our services. The long-term financial impact on our business cannot be reasonably estimated at this time. As a result, the effects
of COVID-19 may not be fully reflected in our financial results until future periods.
Until the effects of the
pandemic and associated inflationary impact have fully receded, we expect business conditions to remain challenging. In response
to these challenges, we will continue to focus on those factors that we can control: closely managing and controlling our expenses; aligning
our design and development schedules with demand in a proactive manner to minimize our cash operating costs; pursuing further improvements
in the productivity and effectiveness of our development, selling and administrative activities and, where appropriate, taking advantage
of opportunities to enhance our business growth and strategy.
Variability of Revenues
and Results of Operations
A significant portion of
our revenue is concentrated with several large customers, some of which are the same and some of which change over time. Orders from some
of these customers can be highly variable, with short lead times, which can cause our quarterly revenues, and consequently our results
of operations, to vary over a relatively short period of time.
Critical Accounting Policies
and Estimates
We discussed the material
accounting policies that are critical in making the estimates and judgments in our Annual Report on Form 10-K for the fiscal year ended
September 30, 2022, under the caption “Management’s Discussion and Analysis—Critical Accounting Policies and Estimates”.
There has been no material change in critical accounting policies or estimates during the period covered by this report.
Recent Accounting Pronouncements
For information on recent
accounting pronouncements and impacts, see Note 2 to the unaudited condensed consolidated financial statements.
RESULTS OF OPERATIONS FOR
THE THREE MONTHS ENDED JUNE 30, 2023 COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2022
Consolidated Results
The table below summarizes our consolidated results
of operations for the 2023 Quarter as compared to the 2022 Quarter:
Consolidated Results of Operations
2023
Quarter
2022
Quarter
Change ($)
Change (%)
Revenues, net
$ 10,127,000
$ 10,589,000
$ (462,000 )
(4.4% )
Cost of sales
8,304,000
8,671,000
(367,000 )
(4.2% )
Gross profit
1,823,000
1,918,000
(95,000 )
(5.0% )
Sales and marketing expenses
711,000
665,000
46,000
6.9%
General and administrative expenses
1,634,000
1,639,000
(5,000 )
(0.3% )
Loss from operations
(522,000 )
(386,000 )
(136,000 )
35.2%
Other expense, net
15,000
33,000
(18,000 )
(54.5% )
Provision for income taxes
–
–
–
–
Net loss
$ (537,000 )
$ (419,000 )
$ (118,000 )
28.2%
21
The discussion that follows
below provides further details about our results of operations for the 2023 Quarter as compared to the 2022 Quarter.
Net revenues decreased in
the OEM distribution segment, primarily related to the loss of a major diabetic customer in March 2023. Higher revenues in the design
and retail distribution segments partially offset this decline. As a result of the Retail Exit, we expect consolidated revenues to decline
in future periods.
Our gross profit decreased,
and our gross margin decreased slightly from 18.1% in the 2022 Quarter to 18.0% in the 2023 Quarter, driven by increased inventory reserves
in the retail segment, partially offset by higher revenues, better utilization and higher billing rates in the design segment. The decrease
was also offset by the loss of a major diabetic customer, which yielded lower margins, coupled with the placement of certain retail products
in physical stores, which yielded higher margins. Management believes there will be continued volatility in OEM and retail distribution
cost of sales for the remainder of fiscal 2023.
Sales and marketing expenses
increased in the 2023 Quarter primarily due to higher commission expense in the design segment due to increased sales and higher sales
promotions in the retail segment, offset by decreases in the sales related salaries in the OEM distribution segment. Sales and marketing
as a percentage of revenues increased to 7.0% in the 2023 Quarter from 6.3% in the 2022 Quarter. As a result of the Retail Exit, we expect
that our sales and marketing expenses will decrease in fiscal 2024.
General and administrative
expenses decreased slightly in the 2023 Quarter. Lower corporate expenses, primarily driven by a reduction in bad debt expense and non-employee
directors share-based compensation expense, were partially offset by higher personnel related costs. Management continues to monitor the
various components of general and administrative expenses and how these costs are affected by inflationary and other factors. We intend
to adjust these costs as needed based on the overall needs of the business.
Higher interest income from
improved treasury management, coupled with lower interest expense resulting from a reduction in the amount of debt outstanding, drove
the change in net other expense.
We generated a net loss of
$537,000 and $419,000 in the 2023 Quarter and 2022 Quarter, respectively. We maintain significant net operating loss carryforwards and
do not recognize a significant income tax expense or benefit as our deferred tax provision is typically offset by a full valuation allowance
on our net deferred tax asset.
Consolidated basic and diluted
loss per share was $0.05 and $0.04 for the 2023 Quarter and the 2022 Quarter, respectively.
Segment Results
The discussion that follows
below provides further details about the results of operations for each segment as compared to the prior year quarter.
Segment Results of Operations
OEM Distribution
Retail Distribution
Design
Corporate Expenses
Consolidated
2023 Quarter revenues
$ 2,930,000
$ 1,420,000
$ 5,777,000
$ –
$ 10,127,000
2022 Quarter revenues
4,775,000
878,000
4,936,000
–
10,589,000
Change
$ (1,845,000 )
$ 542,000
$ 841,000
$ –
$ (462,000 )
2023 Quarter operating income/(loss)
$ 163,000
$ (680,000 )
$ 576,000
$ (581,000 )
$ (522,000 )
2022 Quarter operating income/(loss)
179,000
(397,000 )
447,000
(615,000 )
(386,000 )
Change
$ (16,000 )
$ (283,000 )
$ 129,000
$ 34,000
$ (136,000 )
22
OEM Distribution Segment
The decrease in net revenues
in the OEM distribution segment resulted from lower sales from both diabetic customers and other OEM customers. As consumer demand increases
for diabetic testing products which require no carrying case, we expect diabetic product sales to continue to represent a smaller portion
of our OEM distribution revenue. In March 2023, a contract with one of our major diabetic customers expired. Due to increased pricing
pressures, we did not extend our contract with this customer. Revenue from this customer represented approximately 12% of our consolidated
net revenues in the 2022 Quarter. We expect the loss of this customer to cause a significant decline in OEM distribution segment revenues
in future periods.
The following tables set
forth revenues by product line of our OEM distribution segment customers for the periods indicated:
OEM Revenues by Product Line
2023
Quarter
2022
Quarter
Change ($)
Change (%)
Diabetic products
$ 2,402,000
$ 4,087,000
$ (1,685,000 )
(41.2% )
Other products
528,000
688,000
(160,000 )
(23.3% )
Total net revenues
$ 2,930,000
$ 4,775,000
$ (1,845,000 )
(38.6% )
Diabetic Product Revenues
Our OEM distribution segment
manufactures to the order of, and sells carrying cases for, blood glucose diagnostic kits directly to OEMs (or their contract manufacturers).
The OEM customer or its contract manufacturer packages our carry cases “in box” as a custom accessory for the OEM’s
blood glucose testing and monitoring kits, or to a lesser extent, sells them through their retail distribution channels.
Revenues from diabetic products
decreased due to the loss of one major diabetic customer in March 2023, the loss of one product to a competitor and the net decrease in
volume from other customers resulting from the timing of orders relative to the 2022 Quarter. As mentioned above, management believes
that revenues from diabetic customers will decline in future periods. Revenues from diabetic products represented 82% of net revenues
for the OEM distribution segment in the 2023 Quarter compared to 86% in the 2022 Quarter.
Other Product Revenues
Our OEM distribution segment
also sources and sells cases and protective solutions for a diverse array of portable electronic and non-electronic products (such as
sporting and recreational products, bar code scanners, GPS devices, tablets and firearms) on a made-to-order basis that are customized
to fit the products sold by our OEM customers.
Revenues from other products
decreased due to lower sales volume with some existing customers, which was partially offset by higher sales volume from some other customers.
We will continue to focus on our sales and sales support teams in our continued efforts to expand and diversify our other products customer
base.
Operating Income
Operating income for the
OEM distribution segment decreased but operating income margin increased from 3.7% in the 2022 Quarter to 5.6% in the 2023 Quarter. The
loss of one major diabetic customer in March 2023, which yielded lower margins, reduced revenues and gross profit, but improved gross
margin for this segment. Lower sales and marketing costs resulting from reduced OEM sales personnel also contributed to the improvement.
The cost of importing all products from China has increased and both the diabetic and other OEM product lines have experienced pricing
pressures from customers.
23
Considering the loss of a
significant diabetic customer, management reduced its OEM distribution segment sales and marketing personnel in March 2023 and is currently
assessing the terms of its sourcing agreement with Forward China, which is scheduled to expire on October 22, 2023 (see Note 8 to the
condensed consolidated financial statements). Effective April 1, 2023, the Company and Forward China agreed to reduce the fixed portion
of the sourcing fee from $100,000 to $83,333 per month for the remaining term of the sourcing agreement, which resulted in cash savings
of $50,000 in the third quarter of fiscal 2023 and is expected to result in cash savings of $50,000 for the remainder of the 2023 fiscal
year. The Company and Forward China have begun negotiations on a new sourcing agreement. In light of the Retail Exit, the Company
plans to discuss a further reduction in the sourcing fee commensurate with the services provided. While we believe a new agreement will
be reached, we cannot provide any assurances that we will be successful. If an agreement cannot be reached, which could have a significant
impact on the Company’s operations, we will look at other alternatives for our OEM distribution business prior to the expiration
of the agreement. Management is planning to further evaluate the OEM distribution segment cost structure and implement additional cost
cutting initiatives as deemed necessary.
Retail Distribution Segment
The increase in net revenues
in the 2023 Quarter was driven by higher sales volumes and the placement of certain products in physical stores, which was partially offset
by price reductions on certain other products. As inflation continues to increase the cost of products and constrain consumer spending,
profitability continues to be challenging in the retail segment.
The cost of importation,
storage, and other logistics services, coupled with higher inventory reserves and price reductions on certain products, outpaced revenue
leading to a negative gross profit and margin in the 2023 Quarter. However, margins on some products placed in physical retail stores
slightly offset this. Higher sales and marketing expenses, driven by an increase in marketing promotions to support revenue growth, drove
operating income down further. The operating loss margin increased from 45.2% in the 2022 Quarter to 47.9% in the 2023 Quarter. As mentioned
above, the Company recently decided to implement the Retail Exit. Please see “Liquidity and Capital Resources”.
Design Segment
The increase in net revenues
in the design segment was primarily driven by an increase in revenue from one major customer, coupled with an increase in projects from
new and other existing customers, which was partially offset by declines in revenues from certain prior year customers.
Operating income for the
design segment increased and operating income margin increased from 9.1% in the 2022 Quarter to 10.0% in 2023 Quarter. The impact of better
utilization and increased billing rates was partially offset by higher direct labor costs, driven by inflationary pressures, and slightly
higher personnel related expenses.
RESULTS OF OPERATIONS FOR
THE NINE MONTHS ENDED JUNE 30, 2023 COMPARED TO THE NINE MONTHS ENDED JUNE 30, 2022
Consolidated Results
The table below summarizes our consolidated results
of operations for the 2023 Period as compared to the 2022 Period:
Consolidated Results of Operations
2023
Period
2022
Period
Change ($)
Change (%)
Revenues, net
$ 31,595,000
$ 32,517,000
$ (922,000 )
(2.8% )
Cost of sales
26,341,000
25,728,000
613,000
2.4%
Gross profit
5,254,000
6,789,000
(1,535,000 )
(22.6% )
Sales and marketing expenses
2,175,000
2,106,000
69,000
3.3%
General and administrative expenses
4,912,000
5,177,000
(265,000 )
(5.1% )
Loss from operations
(1,833,000 )
(494,000 )
(1,339,000 )
271.1%
Other expense, net
5,000
101,000
(96,000 )
(95.0% )
Provision for income taxes
–
–
–
–
Net loss
$ (1,838,000 )
$ (595,000 )
$ (1,243,000 )
208.9%
24
The discussion that follows
below provides further details about our results of operations for the 2023 Period as compared to the 2022 Period.
Net revenues declined in
the OEM distribution segment but were partially offset by higher revenues in the retail distribution and design segments. As a result
of the Retail Exit, we expect consolidated revenues to decline in future periods.
Our gross profit decreased
in both our OEM and retail segments, partially offset by a slight increase in gross profit in the design segment. Gross margin declined
from 20.9% in the 2022 Period to 16.6% in the 2023 Period, driven by continued pricing pressures from our customers, high product, importation
and logistics costs, higher retail inventory reserves and inflation. Management believes there will be continued volatility in OEM and
retail distribution cost of sales for the remainder of fiscal 2023.
Sales and marketing expenses
increased slightly primarily due to higher sales related expenses in the design segment, partially offset by lower commissions, travel
and marketing overhead related to our retail segment and lower marketing related overhead in our OEM distribution segment. Sales and marketing
as a percentage of revenues increased slightly from 6.5% in the 2022 Period to 6.9% in the 2023 Period. As a result of the Retail Exit,
we expect that our sales and marketing expenses will decrease in fiscal 2024.
General and administrative
expenses decreased in the 2023 Period, primarily related to bad debt recoveries in the design segment and lower non-employee directors
share-based compensation expense, partially offset by higher professional fees and personnel costs. Management continues to monitor the
various components of general and administrative expenses and how these costs are affected by inflationary and other factors. We intend
to adjust these costs as needed based on the overall needs of the business.
We recorded net other expense
of $5,000 in the 2023 Period compared to $101,000 in the 2022 Period. The variance is due to fair value adjustments of $40,000 in the
2023 Period to reduce to the fair value of the earnout consideration related to the Kablooe acquisition, $18,000 of net duty drawback
income received in the 2023 Period, interest income from improved treasury management, foreign currency fluctuations and a decrease in
interest expense resulting from a reduction in the amount of debt outstanding.
We generated a net loss of
$1,838,000 and $595,000 in the 2023 Period and 2022 Period, respectively. We maintain significant net operating loss carryforwards and
do not recognize a significant income tax expense or benefit as our deferred tax provision is typically offset by a full valuation allowance
on our net deferred tax asset.
Consolidated basic and diluted
loss per share was $0.18 and $0.06 for the 2023 Period and the 2022 Period, respectively.
Segment Results
The discussion that follows
below provides further details about the results of operations for each segment as compared to the prior year period.
Segment Results of Operations
OEM Distribution
Retail Distribution
Design
Corporate Expenses
Consolidated
2023 Period revenues
$ 11,364,000
$ 3,396,000
$ 16,835,000
$ –
$ 31,595,000
2022 Period revenues
14,692,000
2,919,000
14,906,000
–
32,517,000
Change
$ (3,328,000 )
$ 477,000
$ 1,929,000
$ –
$ (922,000 )
2023 Period operating income/(loss)
$ 303,000
$ (1,742,000 )
$ 1,539,000
$ (1,933,000 )
$ (1,833,000 )
2022 Period operating income/(loss)
1,002,000
(981,000 )
1,422,000
(1,937,000 )
(494,000 )
Change
$ (699,000 )
$ (761,000 )
$ 117,000
$ 4,000
$ (1,339,000 )
25
OEM Distribution Segment
Net revenues in the OEM distribution
segment decreased from lower sales volume from both diabetic customers and other OEM customers. As consumer demand increases for diabetic
testing products which require no carrying case, we expect diabetic product sales to continue to represent a smaller portion of our OEM
distribution revenue. In March 2023, a contract with one of our major diabetic customers expired. Due to increased pricing pressures,
we did not extend our contract with this customer. Revenue from this customer represented approximately 12% of our consolidated net revenues
in the 2022 Period. We expect the loss of this customer to cause a significant decline in OEM distribution segment revenues in future
periods.
The following tables set
forth revenues by product line of our OEM distribution segment customers for the periods indicated:
OEM Revenues by Product Line
2023
Period
2022
Period
Change ($)
Change (%)
Diabetic products
$ 9,760,000
$ 12,480,000
$ (2,720,000 )
(21.8% )
Other products
1,604,000
2,212,000
(608,000 )
(27.5% )
Total net revenues
$ 11,364,000
$ 14,692,000
$ (3,328,000 )
(22.7% )
Diabetic Product Revenues
Our OEM distribution segment
manufactures to the order of, and sells carrying cases for, blood glucose diagnostic kits directly to OEMs (or their contract manufacturers).
The OEM customer or its contract manufacturer packages our carry cases “in box” as a custom accessory for the OEM’s
blood glucose testing and monitoring kits, or to a lesser extent, sells them through their retail distribution channels.
Revenues from diabetic products
decreased due to the loss of a major customer in March 2023, lower demand from one major customer and the loss of one product to a competitor.
These decreases were partially offset by an increase in demand from another customer, which was timing related. As mentioned above, management
believes that revenues from diabetic customers will decline in future periods. Revenues from diabetic products represented 86% of net
revenues for the OEM distribution segment in the 2023 Period compared to 85% in the 2022 Period.
Other Product Revenues
Our OEM distribution segment
also sources and sells cases and protective solutions for a diverse array of portable electronic and non-electronic products (such as
sporting and recreational products, bar code scanners, GPS devices, tablets and firearms) on a made-to-order basis that are customized
to fit the products sold by our OEM customers.
Revenues from other products
decreased due to lower sales volume with some existing customers, partially driven by the delayed rollout of certain customer product
lines and reduced demand from some customers. We will continue to focus on our sales and sales support teams in our continued efforts
to expand and diversify our other products customer base.
26
Operating Income
Operating income for the
OEM distribution segment decreased and operating income margin decreased from 6.8% in the 2022 Period to 2.7% in the 2023 Period, driven
by lower gross margins due to lower revenues and a shift in the mix of revenue. While revenues decreased in both diabetic and other products,
the decrease in diabetic revenue was mostly from more profitable products, thus driving overall gross margins down. The cost of importing
all products from China has increased and both the diabetic and other OEM product lines have experienced pricing pressures from customers.
Considering the loss of a
significant diabetic customer, management reduced its OEM distribution segment sales and marketing personnel in March 2023 and is currently
assessing the terms of its sourcing agreement with Forward China, which is scheduled to expire on October 22, 2023 (See Note 8 to the
condensed consolidated financial statements). Effective April 1, 2023, the Company and Forward China agreed to reduce the fixed portion
of the sourcing fee from $100,000 to $83,333 per month for the remaining term of the sourcing agreement, which resulted in cash savings
of $50,000 in the third quarter of fiscal 2023 and is expected to result in cash savings of $50,000 for the remainder of the 2023 fiscal
year. The Company and Forward China have begun negotiations on a new sourcing agreement. In light of the Retail Exit, the Company
plans to discuss a further reduction in the sourcing fee commensurate with the services provided. While we believe a new agreement will
be reached, we cannot provide any assurances that we will be successful. If an agreement cannot be reached, which could have a significant
impact on the Company’s operations, we will look at other alternatives for our OEM distribution business prior to the expiration
of the agreement. Management is planning to further evaluate the OEM distribution segment cost structure and implement additional cost
cutting initiatives as deemed necessary.
Retail Distribution Segment
Net revenues increased in
the 2023 Period due to an increase in sales volumes on some products with certain existing customers and the placement of certain products
in physical stores, partially offset by price reductions on certain other products. As inflation continues to increase the cost of products
and constrain consumer spending, profitability continues to be challenging in the retail segment.
The cost of importation,
storage, and other logistics services, coupled with higher inventory reserves and price reductions on certain products, outpaced revenue
leading to a decline in gross margin from the 2022 Period to the 2023 Period. This was partially offset by lower sales and marketing expenses
driven by a reduction in commission expense resulting from a change in the mix of revenue. The operating loss margin increased from 33.6%
in the 2022 Period to 51.3% in the 2023 Period. As mentioned above, the Company recently decided to implement the Retail Exit. Please
see “Liquidity and Capital Resources”.
Design Segment
The increase in net revenues
in the design segment was driven by an increase in revenue from one major customer, coupled with an increase in projects from new and
existing customers, which was partially offset by declines in revenues from certain prior year customers.
Operating income for the
design segment increased slightly but operating income margin decreased from 9.5% in the 2022 Period to 9.1% in 2023 Period. The impact
of higher direct labor costs driven by inflationary pressures, coupled with higher sales and marketing expenses, was slightly offset by
better utilization and increased billing rates and lower general and administrative expenses, driven by bad debt recoveries.
27
LIQUIDITY AND CAPITAL RESOURCES
Our primary source of liquidity
is our operations. The primary demand on our working capital has historically been (i) operating losses, (ii) repayment of debt obligations,
and (iii) any increases in accounts receivable and inventories arising in the ordinary course of business. Historically, our sources of
liquidity have been adequate to satisfy working capital requirements arising in the ordinary course of business. At June 30, 2023, our
working capital was $2,476,000 compared to $4,359,000 at September 30, 2022, the decrease was primarily due to lower inventory balances.
At July 31, 2023, we had approximately $3,000,000 cash on hand and $1,300,000 available under our line of credit with a bank which was
renewed in March 2023 and matures May 31, 2024. Considering the loss of a significant OEM distribution segment customer (see Note 5 to
the condensed consolidated financial statements), which led to the April 2023 reduction in the sourcing fee to Forward China, and the
continued retail distribution segment operating losses, management reduced its OEM segment sales and marketing personnel in March 2023
and is planning to further evaluate the Company’s OEM cost structure and implement additional cost cutting initiatives as deemed
necessary. Additionally, in July 2023, the Company decided to implement the Retail Exit. The Company is working on a plan that will ensure
the transition out of the retail business is done in an orderly manner while also satisfying existing customer obligations. At this time,
the Company does not know the extent, or a range, of the costs that it will incur as a result of the exit.
Forward China, our largest
vendor and an entity owned by our Chairman of the Board and Chief Executive Officer, holds a $1,600,000 promissory note (the “FC
Note”) issued by us which matures on December 31, 2024 (see Note 8 to the condensed consolidated financial statements). The balance
of the FC Note was reduced to $1,200,000 after we made principal payments of $400,000 through June 30, 2023. Although the FC Note has
been extended on multiple occasions to assist us with our liquidity position, we plan on funding the repayment at maturity using existing
cash balances and/or obtaining an additional credit facility as deemed necessary. Additionally, Forward China has extended payment terms
on our outstanding payables due to them when necessary. At June 30, 2023, our accounts payable due to Forward China was approximately
$8,000,000. We can provide no assurance that (i) Forward China will extend the FC Note again if we request an extension, (ii) Forward
China will continue to extend payment terms on outstanding payables when we need them, or (iii) any additional credit facility will be
available on terms acceptable to us or at all.
We anticipate that our liquidity
and financial resources for the 12 months following the date of this report will be adequate to manage our operating and financial requirements.
If we have the opportunity to make a strategic acquisition (as we have in the past with the acquisitions of IPS and Kablooe) or an investment
in a product or partnership, we may require additional capital beyond our current cash balance to fund the opportunity. If we seek to
raise additional capital, there is no assurance that we will be able to raise funds on terms that are acceptable to us or at all. In the
current environment of rising interest rates, any future borrowing is expected to result in higher interest expense.
Although we do not anticipate
the need to purchase additional material capital assets in order to carry out our business, it may be necessary for us to purchase equipment
and other capital assets in the future, depending on need.
Cash Flows
During the 2023 Period and
2022 Period, our sources and uses of cash were as follows:
Operating
Activities
During the 2023 Period, cash
provided by operating activities of $562,000 resulted from a decrease in inventories of $1,908,000, an increase in accounts payable and
amounts due to Forward China of $651,000, non-cash expenses of $271,000 related to fair value adjustments, depreciation, amortization,
share-based compensation and bad debt expense, an increase in accrued expenses and other current liabilities of $129,000 and the net change
in other operating assets and liabilities of $24,000, partially offset by a net loss of $1,838,000, an increase in prepaid expenses and
other current assets of $272,000, a decrease in deferred income of $174,000 and an increase in accounts receivable of $137,000.
28
During
the 2022 Period, cash provided by operating activities of $1,158,000 resulted from an increase in accounts payable and amounts due to
Forward China of $3,064,000, an increase in accrued expenses and other liabilities of $546,000, an increase in deferred revenue of $436,000,
non-cash expenses of $442,000 related to depreciation, amortization, share-based compensation and bad debt expense and the net change
in other operating assets and liabilities of $74,000, partially offset by a $2,809,000 increase in inventories and a net loss of $595,000.
Investing
Activities
Cash used in investing activities
in the 2023 Period and the 2022 Period of $117,000 and $140,000, respectively, resulted from purchases of property and equipment.
Financing
Activities
Cash used in financing activities
in the 2023 Period and the 2022 Period of $200,000 and $150,000, respectively, consisted of principal payments on the promissory note
held by Forward China.
Related Party Transactions
For information on related
party transactions and their financial impact, see Note 8 to the unaudited condensed consolidated financial statements contained herein.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.